Brain-derived peptides increase blood-brain barrier GLUT1 glucose transporter gene expression via mRNA stabilization

Neuroscience Letters

Volumn 255, Issue 3, 1998, Pages 147-150

  Boado, Ruben J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Blood brain barrier; Brain peptides; Cerebrolysin; Enzyme linked immunosorbent assay; Gene regulation; Glucose transporter; GLUT1; mRNA

Indexed keywords

GLUCOSE TRANSPORTER; MESSENGER RNA;

ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE EXPRESSION REGULATION; GLUCOSE TRANSPORT; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN STABILITY; RNA METABOLISM;

AMINO ACIDS; BLOOD-BRAIN BARRIER; CELLS, CULTURED; CEREBROVASCULAR CIRCULATION; DRUG STABILITY; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GLUCOSE TRANSPORTER TYPE 1; HUMANS; MONOSACCHARIDE TRANSPORT PROTEINS; RNA, MESSENGER;

EID: 0032561338     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(98)00731-9     Document Type: Article

References (20)

1. Akai F., Himura S., Sato T., Iwamoto N., Fujimoto M., Ioku M., Hashimoto S. Neurotrophic factor-like effect of FPF1070 on septal cholinergic neurons after transections of fimbria-fornix in the rat. Histol. Histopathol. 7:1992;213-221.
2. Boado R.J. Brain-derived peptides regulate the steady state levels and increase stability of the blood-brain barrier GLUT1 glucose transporter mRNA. Neurosci. Lett. 197:1995;179-182.
3. Boado R.J. Brain-derived peptides increase the expression of a blood-brain barrier GLUT1 glucose transporter reporter gene. Neurosci. Lett. 220:1996;53-56.
4. Boado R.J. Modulation of blood-brain barrier GLUT1 glucose transporter gene expression by brain-derived peptides. J. Neural Transm. (Suppl.). 53:1998;323-331.
5. Boado R.J., Pardridge W.M. Molecular cloning of the bovine blood-brain barrier glucose transporter cDNA and demonstration of phylogenetic conservation of the 5′-untranslated region. Mol. Cell. Neurosci. 1:1990;224-232.
6. Boado R.J., Pardridge W.M. Glucose deprivation causes post-transcriptional enhancement of brain capillary endothelial glucose transporter gene expression via GLUT1 mRNA stabilization. J. Neurochem. 60:1993;2290-2296.
7. Boado R.J., Tsukamoto H., Pardridge W.M. Evidence for transcriptional control elements in 5′-untranslated region of GLUT1 glucose transporter mRNA. J. Neurochem. 67:1996;1335-1343.
8. DeBault L.E., Cancilla P.A. Gamma glutamyl transpeptidase in isolated brain endothelial cells: induction by glial cells in vitro. Science. 207:1980;653-655.
9. Flier J.S., Mueckler M., McCall A.L., Lodish H.F. Distribution of glucose transporter messenger RNA transcripts in tissues of rat and man. J. Clin. Invest. 79:1987;657-661.
10. McGowan K.M., Police S., Winslow J.B., Pekala P.H. Tumor necrosis factor-α regulation of glucose transporter (GLUT1) mRNA turnover: contribution of the 3′-untranslated region of the GLUT1 message. J. Biol. Chem. 272:1997;1331-1337.
11. Mueckler M., Caruso C., Baldwin S.A., Panico M., Blench I., Morris H.R., Allard W.J., Lienhard G.E., Lodish H.F. Sequence and structure of a human glucose transporter. Science. 229:1985;941-945.
12. Pardridge, W.M. and Boado, R.J., Molecular cloning and regulation of gene expression of blood-brain barrier glucose transporter. In the Blood-Brain Barrier: Cellular and Molecular Biology, Raven Press, New York, 1993, pp. 395-440.
13. Rajagopalan L.E., Malter J.S. Turnover and translation of in vitro synthesized messenger RNAs in transfected, normal cells. J. Biol. Chem. 271:1996;19871-19876.
14. Ruther E., Ritter R., Apecechea M., Freytag S., Windisch M. Efficacy of the peptidergic nootropic drug cerebrolysin in patients with senile dementia of the Alzheimer type (SDAT). Pharmacopsychiatry. 27:1994;32-40.
15. Sandouk T., Reda D., Hofmann C. The antidiabetic agent pioglitazone increases expression of glucose transporters in 3T3-F442A cells by increasing messenger ribonucleic acid transcript stability. Endocrinology. 133:1993;352-359.
16. Stewart P.A., Wiley M.J. Developing nervous tissue induces formation of blood-brain barrier characteristics in invading endothelial cells: a study using quail-chick transplantation chimera. Dev. Biol. 84:1981;183-192.
17. Takakura Y., Kuentzel S.L., Raub T.J., Davies A., Baldwin S.A., Borchardt R.T. Hexose uptake in primary cultures of bovine brain microvessel endothelial cells. 1. Basic characteristics and effects of glucose and insulin. Biochim. Biophys. Acta. 1070:1991;1-10.
18. Takata K., Kasahara T., Kasahara M., Ezaki O., Hirano H. Erythrocyte/HepG2-type glucose transporter is concentrated in cells of blood-tissue barriers. Biochem. Biophys. Res. Commun. 173:1990;67-73.
19. Tsukamoto H., Boado R.J., Pardridge W.M. Site-directed deletion of a 10-nucleotide domain of the 3′-untranslated region of the GLUT1 glucose transporter mRNA eliminates cytosolic protein binding in human brain tumors and induction of reporter gene expression. J. Neurochem. 68:1997;2587-2692.
20. Xiong H., Wojtowicz J.M., Baskys A. Brain tissue hydrolysate acts on presynaptic adenosine receptors in the rat hippocampus. Can. J. Physiol. Pharmacol. 73:1995;1194-1197.